Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCW2M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,292
Award facts
- Contract value 100% obligated
- $15,291.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,291.86 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of TREMFYA 200 mg/2 mL pens (a prescription medication used to treat certain inflammatory skin conditions). This firm fixed-price contract, with an ultimate completion date of January 14, 2026, represents a non-competitive set-aside award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated capability to meet federal requirements through its extensive portfolio of competitive contract awards covering diverse pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role in supporting the department's pharmaceutical supply chain and reflects DLA's reliance on established prime vendor relationships to ensure timely procurement of specialized medical products for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FCW2M?
SPE2DR26FCW2M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FCW2M worth?
The government has obligated $15,292 on SPE2DR26FCW2M.
Is contract SPE2DR26FCW2M an order under another contract?
Yes. SPE2DR26FCW2M is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW2M competed?
The extent of competition for SPE2DR26FCW2M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award